OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TUBA57

Tubacex SA

Iron & SteelVerified

Tubacex operates with a fully diluted share count of 122.7 million shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics for Tubacex are not available in the current dataset, and no direct comparison to industry medians can be made. However, the company's operations in the Iron & Steel industry suggest that it is subject to the same cyclical pressures and margin volatility as its peers. Tubacex's revenue is concentrated in a few geographic regions, primarily in Spain and other parts of Europe. The company does not disclose detailed segment data, so the extent of geographic diversification is unclear. The company's growth trajectory is not quantified in the current dataset, but analyst price targets suggest a range of expectations, with a mean of 4.37 EUR and a median of 4.15 EUR. The mean recommendation of 2.00 indicates a generally positive outlook from analysts. Tubacex faces low dilution risk, as no dilutive instruments are currently outstanding. The absence of balance-sheet data prevents a full assessment of liquidity risk, but the company's capital structure appears stable. Recent filings and transcripts are not available in the current dataset, so no specific events can be cited as influencing the company's performance or outlook.

30-day price · TUBA-0.24 (-7.4%)
Low$2.75High$3.38Close$2.98As of25 May, 00:00 UTC
Profile
CompanyTubacex SA
TickerTUBA.MC
SectorBasic Materials
BusinessMineral Resources
Industry groupMineral Resources
IndustryIron & Steel
AI analysis

Business. Tubacex SA is a mining company engaged in the production and sale of copper and other base metals, primarily operating in Spain and other European countries.

Classification. Tubacex is classified under the Basic Materials economic sector, within the Mineral Resources business sector, and the Iron & Steel industry, with a classification confidence of 0.92.

Tubacex operates with a fully diluted share count of 122.7 million shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible securities. The company's liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics for Tubacex are not available in the current dataset, and no direct comparison to industry medians can be made. However, the company's operations in the Iron & Steel industry suggest that it is subject to the same cyclical pressures and margin volatility as its peers. Tubacex's revenue is concentrated in a few geographic regions, primarily in Spain and other parts of Europe. The company does not disclose detailed segment data, so the extent of geographic diversification is unclear. The company's growth trajectory is not quantified in the current dataset, but analyst price targets suggest a range of expectations, with a mean of 4.37 EUR and a median of 4.15 EUR. The mean recommendation of 2.00 indicates a generally positive outlook from analysts. Tubacex faces low dilution risk, as no dilutive instruments are currently outstanding. The absence of balance-sheet data prevents a full assessment of liquidity risk, but the company's capital structure appears stable. Recent filings and transcripts are not available in the current dataset, so no specific events can be cited as influencing the company's performance or outlook.
Key takeaways
  • Tubacex operates in the Iron & Steel industry with a focus on copper and base metals.
  • The company has no dilutive shares outstanding, indicating a stable capital structure.
  • Analysts have a generally positive outlook, with a mean price target of 4.37 EUR.
  • The company's liquidity risk could not be assessed due to missing balance-sheet data.
  • Revenue concentration in Spain and Europe suggests exposure to regional economic conditions.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$341.9M-$31.1M-$32.2M-$21.1M
FY-3$714.7M$44.5M$20.2M$44.1M
FY-2$852.4M$80.7M$36.3M$16.3M
FY-1$767.5M$63.5M$22.9M-$32.7M
FY0$719.3M$8.9M-$31.3M-$67.3M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$1.04B$197.4M
FY-3$1.16B$221.5M
FY-2$1.21B$240.0M
FY-1$1.33B$378.0M
FY0$1.22B$292.3M
PeriodOCFCapExFCFSBC
FY-4-$23.9M-$26.7M-$21.1M
FY-3$87.6M-$26.8M$44.1M
FY-2$91.2M-$62.9M$16.3M
FY-1-$33.8M-$87.0M-$32.7M
FY0-$13.6M-$66.2M-$67.3M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6$171.1M
FQ-5
FQ-4$182.3M
FQ-3
FQ-2$164.4M
FQ-1
FQ0$154.2M$7.4M$1.3M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6$1.25B$236.1M$139.2M
FQ-5
FQ-4$1.35B$368.6M$167.1M
FQ-3
FQ-2$1.31B$351.0M$124.8M
FQ-1
FQ0$1.22B$294.1M$158.0M
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Mining · cohort 905 companies
MetricTUBAActivity
Op margin3.5% medp25 -0.6% · p75 10.5%
Net margin2.2% medp25 -1.4% · p75 8.1%
Gross margin13.1% medp25 5.9% · p75 24.5%
R&D / revenue0.5% medp25 0.4% · p75 0.5%
CapEx / revenue-4.4% medp25 -14.2% · p75 -1.7%
Debt / equity21.9% medp25 0.9% · p75 72.4%
Observations
IR observations
Mean price target4.37 EUR
Median price target4.15 EUR
High price target5.60 EUR
Low price target3.50 EUR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count5.00
Hold count1.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.12 EUR
Last actual EPS-0.25 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-25 01:51 UTC#253a6961
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 19:36 UTCJob: 8d619be8